1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Tobacco treatment incorporating contingency management, nicotine replacement therapy, and behavioral counseling for pregnant women who use substances: a feasibility trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Introduction

          Most pregnant women with substance use problems smoke, and few will quit during their pregnancy. Tobacco treatment is often overlooked, with the focus usually placed on other substance use. Additionally, few targeted effective treatments for this group exist. To address this, the feasibility of an intensive tobacco treatment incorporating contingency management (CM) that featured non–face-to-face delivery was examined.

          Methods

          A single-arm pre-post design feasibility trial was conducted in three antenatal services that support women who use substances in metropolitan Australia. Participants were over the age of 15, had <33-week gestation, and smoked tobacco daily. They received financial incentives for daily carbon monoxide-verified smoking abstinence or reduction through an internet-based CM programme, nicotine replacement therapy (NRT) posted to women and partners or household members who smoked and telephone-delivered behavioral counseling from study enrolment to birth.

          Results

          Of the 101 referrals, 46 women (46%) consented. The mean (SD) age was 31(±6) years, and the gestation period was 22(±6) weeks. Nineteen (41%) of those enrolled were retained for 12-week postpartum. Of 46 women, 32 (70%) utilized CM; 32 (70%) used NRT for ≥2 weeks; 23 (50%) attended ≥1 counseling session; and 15 (22%) received NRT for partners/household members. Fifteen (33%) were verified abstinent from tobacco at delivery after a median (IQR) period of abstinence of 65(36–128) days. All non-smokers at birth utilized NRT and financial incentives, and 9/15 (60%) utilized counseling. Four (9%) were abstinent at 12-week postpartum. Median cigarettes smoked/day reduced from baseline to delivery (10(6–20) to 1(0-6) p =< 0.001). Women who quit smoking had more education (72% vs. 33% p =< 0.02), completed more CO samples (median (IQR) 101(59–157) vs. 2(0–20) p =< 0.001), and received more incentives (median (IQR) $909($225–$1980) vs. $34($3–$64) p =< 0.001). Intervention acceptability was rated favorably by participants (9 items rated 0–10 with scores >5 considered favorable).

          Discussion

          This study demonstrated the feasibility and acceptability of a consumer-informed, non–face-to-face intensive tobacco treatment, highlighting the potential of remotely delivered technology-based CM to reduce the health impact of tobacco smoking in high-priority populations. The intervention demonstrates scale-up potential. Future studies should extend treatment into the postpartum period, utilizing new technologies to enhance CM delivery and improve counseling provision and partner support.

          Clinical trial registration

          https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374196, ACTRN1261800056224.

          Related collections

          Most cited references74

          • Record: found
          • Abstract: found
          • Article: not found

          Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

          Research electronic data capture (REDCap) is a novel workflow methodology and software solution designed for rapid development and deployment of electronic data capture tools to support clinical and translational research. We present: (1) a brief description of the REDCap metadata-driven software toolset; (2) detail concerning the capture and use of study-related metadata from scientific research teams; (3) measures of impact for REDCap; (4) details concerning a consortium network of domestic and international institutions collaborating on the project; and (5) strengths and limitations of the REDCap system. REDCap is currently supporting 286 translational research projects in a growing collaborative network including 27 active partner institutions.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            A brief measure for assessing generalized anxiety disorder: the GAD-7.

            Generalized anxiety disorder (GAD) is one of the most common mental disorders; however, there is no brief clinical measure for assessing GAD. The objective of this study was to develop a brief self-report scale to identify probable cases of GAD and evaluate its reliability and validity. A criterion-standard study was performed in 15 primary care clinics in the United States from November 2004 through June 2005. Of a total of 2740 adult patients completing a study questionnaire, 965 patients had a telephone interview with a mental health professional within 1 week. For criterion and construct validity, GAD self-report scale diagnoses were compared with independent diagnoses made by mental health professionals; functional status measures; disability days; and health care use. A 7-item anxiety scale (GAD-7) had good reliability, as well as criterion, construct, factorial, and procedural validity. A cut point was identified that optimized sensitivity (89%) and specificity (82%). Increasing scores on the scale were strongly associated with multiple domains of functional impairment (all 6 Medical Outcomes Study Short-Form General Health Survey scales and disability days). Although GAD and depression symptoms frequently co-occurred, factor analysis confirmed them as distinct dimensions. Moreover, GAD and depression symptoms had differing but independent effects on functional impairment and disability. There was good agreement between self-report and interviewer-administered versions of the scale. The GAD-7 is a valid and efficient tool for screening for GAD and assessing its severity in clinical practice and research.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment.

                Bookmark

                Author and article information

                Contributors
                Journal
                Front Psychiatry
                Front Psychiatry
                Front. Psychiatry
                Frontiers in Psychiatry
                Frontiers Media S.A.
                1664-0640
                16 August 2023
                2023
                : 14
                : 1207955
                Affiliations
                [1] 1Hunter New England Health Local Health District , Newcastle, NSW, Australia
                [2] 2School of Medicine and Public Health, University of Newcastle , Callaghan, NSW, Australia
                [3] 3Hunter Medical Research Institute , New Lambton Heights, NSW, Australia
                [4] 4Drug and Alcohol Clinical Research Improvement Network , St. Leonards, NSW, Australia
                [5] 5College of Medicine and Public Health, Flinders University , Bedford Park, SA, Australia
                [6] 6Edith Collins Centre, Sydney Local Health District , Camperdown, NSW, Australia
                [7] 7Sydney Medical School, University of Sydney , Sydney, NSW, Australia
                [8] 8Department of Medicine, University of Melbourne , Parkville, VIC, Australia
                [9] 9Women's Alcohol and Drug Service, The Royal Women's Hospital , Parkville, VIC, Australia
                [10] 10Faculty of Health, Southern Cross University , Coffs Harbour, NSW, Australia
                Author notes

                Edited by: Anne Eden Evins, Massachusetts General Hospital, United States

                Reviewed by: Yukiko Washio, RTI International, United States; Joanna M. Streck, Harvard Medical School, United States

                *Correspondence: Melissa A. Jackson Mel.Jackson@ 123456health.nsw.gov.au

                †These authors share senior authorship

                Article
                10.3389/fpsyt.2023.1207955
                10467262
                37654991
                041ba5ce-fe5d-4053-aa34-45405ce8f12f
                Copyright © 2023 Jackson, Brown, Baker, Bonevski, Haber, Bonomo, Blandthorn, Attia, Perry, Barker, Gould and Dunlop.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 18 April 2023
                : 17 July 2023
                Page count
                Figures: 1, Tables: 2, Equations: 0, References: 77, Pages: 12, Words: 8937
                Funding
                This study was supported by a New South Wales Health Translational Research Grant Scheme grant (Reference number 283). Melissa Jackson was supported to complete this study with funding from the New South Wales Health Ph.D. Scholarship Program.
                Categories
                Psychiatry
                Clinical Trial
                Custom metadata
                Addictive Disorders

                Clinical Psychology & Psychiatry
                tobacco treatment,smoking cessation,substance use disorders,pregnancy,contingency management,counseling,nicotine replacement therapy

                Comments

                Comment on this article